COMMUNIQUÉS West-GlobeNewswire

Cannara annonce la modification et l’augmentation de la facilité de crédit accordée par BMO afin de soutenir l’expansion de ses installations à Valleyfield
21/08/2025
La facilité de crédit élargie servira à financer la construction initiale post-récolte à Valleyfield, soutenant ainsi l’objectif à long terme de la Société d’atteindre une capacité annuelle de 100 000 kg MONTRÉAL, 21 [...]
Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield
21/08/2025
Expanded credit facility to fund initial post-harvest buildout at Valleyfield, supporting the Company’s long-term goal of reaching 100,000 kg annual capacity MONTREAL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech [...]
Skye Bioscience to Participate in Upcoming Investment and Medical Conferences
21/08/2025
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health [...]
Castle Biosciences to Participate in Upcoming Investor Conferences
21/08/2025
FRIENDSWOOD, Texas, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management [...]
BioStem Technologies Announces Insider Share Purchase by Chairman and Chief Executive Officer
21/08/2025
POMPANO BEACH, Fla., Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for [...]
I-Mab to Participate in September Investor Conferences
21/08/2025
ROCKVILLE, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, [...]
Unleashing the Spirit of Adventure: Breckenridge Distillery Launches Mountain Shot, a Bold New Mushroom-Infused Elixir
21/08/2025
Mountain Shot Delivers an Elevated Whiskey Experience, Blending Smooth Chocolate Notes with a Refreshing Hint of Mint BRECKENRIDGE, Colo., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery , an award-winning [...]
Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book
21/08/2025
SOLANA BEACH, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI [...]
BioCryst to Present at Upcoming Investor Conference
21/08/2025
RESEARCH TRIANGLE PARK, N.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the Cantor Global Healthcare Conference in New York on [...]
Kraig Biocraft Laboratories Announces Commencement of Full Operations at Second Production Rearing Center in Southeast Asia
21/08/2025
Parallel facilities strengthen continuous production and accelerate spider silk advancements ANN ARBOR, Mich., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs [...]
BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.
21/08/2025
This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home Neurolief’s breakthrough Proliv ™ Rx device is pending Premarket [...]
InflaRx Announces Participation in September Investor Conferences
21/08/2025
JENA, Germany, Aug. 21, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced it will participate [...]
Pyxis Oncology to Participate in September Investor and Industry Conferences
21/08/2025
BOSTON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing antibody-drug conjugate (ADC) therapeutics for difficult-to-treat cancers, today announced that Lara S. [...]
Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%
21/08/2025
COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%. Ester Baiget, President & CEO: “I’m very pleased with 9% organic sales growth in [...]
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
21/08/2025
Mynzepli ® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD) Approval is based on [...]
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
21/08/2025
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD) Approval is based on [...]
Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants
21/08/2025
WALTHAM, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced the pricing of an underwritten public offering of 74,811,404 shares of its common stock at an offering price of $0 [...]
Interim Report Q2 2025: Commercial and operational agility drove market share gains and 46% EBITA growth
21/08/2025
Highlights The Hearing division delivered 8% organic revenue growth driven by broad-based market share gains of ReSound Vivia across global markets growing below structural trends. The strong growth led to 12% growth in [...]
Herantis Pharma releases 1H 2025 report today
21/08/2025
Espoo, Finland, 21 August 2025: Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop Parkinson’s disease, releases today the Company’s 1H 2025 report. The full report [...]

Pages